THU071 Key Device Attributes For Injectable SRL Therapy In Acromegaly And NETs To Aid Clinical Decision Making

Disclosure: W.W. de Herder: Research Investigator; Self; Novartis Pharmaceuticals. Speaker; Self; Novartis Pharmaceuticals, Ipsen. S. Melmed: Consulting Fee; Self; Ionis Pharmaceuticals Inc., Ipsen, Novo Nordisk. Grant Recipient; Self; Pfizer Global R&D. C. Follin: None. W. Geilvoet: None. J.O....

Descripción completa

Detalles Bibliográficos
Autores principales: de Herder, Wouter W, Melmed, Shlomo, Follin, Cecilia, Geilvoet, Wanda, Jorgensen, Jens Otto, Kolarova, Teodora, Marks, Muriël, Martin, Wendy, Geerlings-Grootscholten, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Neuroendocrinology And Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555795/
http://dx.doi.org/10.1210/jendso/bvad114.1151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555795/
http://dx.doi.org/10.1210/jendso/bvad114.1151

Ejemplares similares